Header cover image

South Korean (KOSPI) Life Sciences Industry Analysis

UpdatedDec 11, 2025
DataAggregated Company Financials
Companies27
  • 7D0.5%
  • 3M5.7%
  • 1Y24.7%
  • YTD25.7%

The Life Sciences is pretty flat in the last 7 days, but Curiox Biosystems has stood out, gaining 3.9%. The past year has been better, since the industry has gained 25% in that time. Looking forward, earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the South Korean Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 11 Dec 2025₩94.4t₩6.4t₩1.5t17.1x63.2x14.8x
Sat, 08 Nov 2025₩102.1t₩5.8t₩1.2t14.9x86.1x17.5x
Mon, 06 Oct 2025₩87.4t₩5.8t₩1.2t14.6x73.7x14.9x
Wed, 03 Sep 2025₩86.1t₩5.9t₩1.2t14.3x72.7x14.7x
Fri, 01 Aug 2025₩90.1t₩5.7t₩1.2t16.7x73.5x15.9x
Sun, 29 Jun 2025₩82.3t₩5.6t₩1.2t15.2x67.6x14.6x
Tue, 27 May 2025₩86.0t₩5.6t₩1.2t16.3x70.5x15.4x
Thu, 24 Apr 2025₩86.5t₩5.2t₩1.0t18.1x84.4x16.6x
Sat, 22 Mar 2025₩86.0t₩5.2t₩999.9b10.2x86x16.6x
Mon, 17 Feb 2025₩93.0t₩5.0t₩965.6b13.1x96.3x18.6x
Wed, 15 Jan 2025₩81.9t₩5.0t₩965.6b13.4x84.8x16.4x
Fri, 13 Dec 2024₩76.6t₩5.0t₩965.6b12.9x79.3x15.3x
Sun, 10 Nov 2024₩80.6t₩4.8t₩885.3b13.2x91.1x16.6x
Tue, 08 Oct 2024₩78.8t₩4.8t₩885.3b14.2x89x16.3x
Thu, 05 Sep 2024₩74.1t₩4.8t₩885.3b13.4x83.7x15.3x
Sat, 03 Aug 2024₩71.6t₩4.5t₩731.7b16.7x97.9x15.8x
Mon, 01 Jul 2024₩57.9t₩4.6t₩691.8b21.4x83.7x12.6x
Wed, 29 May 2024₩58.6t₩4.6t₩698.0b19x84x12.7x
Fri, 26 Apr 2024₩62.8t₩4.7t₩654.7b20x95.9x13.5x
Sun, 24 Mar 2024₩66.7t₩4.6t₩656.5b19.8x101.6x14.4x
Tue, 20 Feb 2024₩64.2t₩4.5t₩714.4b34.1x89.8x14.2x
Thu, 18 Jan 2024₩59.6t₩4.5t₩714.4b33.3x83.4x13.2x
Sat, 16 Dec 2023₩55.7t₩4.5t₩721.5b30.5x77.1x12.3x
Mon, 13 Nov 2023₩57.0t₩4.4t₩660.9b21.7x86.2x13x
Wed, 11 Oct 2023₩57.4t₩4.4t₩660.9b34.8x86.8x13.1x
Fri, 08 Sep 2023₩57.6t₩4.4t₩660.0b25.5x87.3x13.1x
Sun, 06 Aug 2023₩62.0t₩4.2t₩673.4b28.9x92.1x14.8x
Tue, 04 Jul 2023₩58.1t₩4.2t₩673.4b30.3x86.3x13.9x
Thu, 01 Jun 2023₩61.4t₩4.3t₩615.2b32.7x99.7x14.3x
Sat, 29 Apr 2023₩60.9t₩4.1t₩626.3b27.1x97.3x14.9x
Mon, 27 Mar 2023₩61.8t₩4.0t₩711.1b26x86.9x15.3x
Wed, 22 Feb 2023₩62.6t₩3.5t₩427.8b21.5x146.2x18x
Fri, 20 Jan 2023₩62.4t₩3.5t₩426.6b20.2x146.4x17.9x
Sun, 18 Dec 2022₩65.2t₩3.4t₩428.7b24.3x152x19x
Price to Earnings Ratio

152x


Total Market Cap: ₩65.2tTotal Earnings: ₩428.7bTotal Revenue: ₩3.4tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Life Sciences Industry Price to Earnings3Y Average 90.6x202320242025
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 63.2x which is lower than its 3-year average PE of 90.6x.
  • The industry is trading close to its 3-year average PS ratio of 15.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 52% per year over the last three years.
  • Revenues for these companies have grown 23% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market2.20%
Healthcare-0.89%
Life Sciences0.51%
Clinical Research and Equipment0.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A445680 Curiox Biosystems₩95.50k5.5%
+₩85.4b
397.7%PS383.2x
A220100 FutureChemLtd₩34.20k6.2%
+₩44.8b
100.7%PS40.9x
A039860 NanoEntek₩4.23k35.9%
+₩42.5b
26.7%PE60.1x
A223250 DreamCIS₩5.68k16.0%
+₩18.7b
91.6%PE7.3x
A296160 Progen₩8.18k6.5%
+₩7.1b
23.4%n/a

Latest News